ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
98,322.24
0.12%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Vertex Pharmaceuticals Inc (0QZU) Cotización

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Inc (0QZU)

LSE
156.22
0.00
(0.00%)
Cerrado 05 Enero 10:30AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
156.22
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
2,479
0.00 Rango del Día 0.00
156.22 Rango de 52 semanas 156.22
Capitalización de Mercado [m]
40.255B
Precio Anterior
156.22
Precio de Apertura
-
Hora
38
@
410.495
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
4,321
Acciones en circulación
257,683,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
29.38
Beneficio por acción (BPA)
13.86
turnover
9.92B
Beneficio neto
3.57B

Acerca de Vertex Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.vrtx.com
Sede
Boston, Massachusetts, USA
Fundado
-
Vertex Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QZU. The last closing price for Vertex Pharmaceuticals was US$156.22. Over the last year, Vertex Pharmaceuticals shares have traded in a share price range of US$ 156.22 to US$ 156.22.

Vertex Pharmaceuticals currently has 257,683,000 shares in issue. The market capitalisation of Vertex Pharmaceuticals is US$40.26 billion. Vertex Pharmaceuticals has a price to earnings ratio (PE ratio) of 29.38.

0QZU Últimas noticias

Más noticias

GLOBAL TRADING UPDATE SUMMARY: Murata's First-Quarter Profit Drops 15%

The following is a round-up of earnings and trading updates by Global companies, issued last week and not separately ...

03 Agosto 2020
Alliance News
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
100156.22156.22156.223786156.22DE
400156.22156.22156.223389156.22DE
1200156.22156.22156.224321156.22DE
2600156.22156.22156.223464156.22DE
5200156.22156.22156.222689156.22DE
15600156.22156.22156.225293156.22DE
26000156.22156.22156.223856156.22DE

0QZU - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Vertex Pharmaceuticals?
El precio actual de las acciones de Vertex Pharmaceuticals es US$ 156.22
¿Cuántas acciones de Vertex Pharmaceuticals están en circulación?
Vertex Pharmaceuticals tiene 257,683,000 acciones en circulación
¿Cuál es la capitalización de mercado de Vertex Pharmaceuticals?
La capitalización de mercado de Vertex Pharmaceuticals es USD 40.26B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Vertex Pharmaceuticals?
Vertex Pharmaceuticals ha negociado en un rango de US$ 156.22 a US$ 156.22 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Vertex Pharmaceuticals?
El ratio precio/beneficio de Vertex Pharmaceuticals es 29.38
¿Cuál es el ratio de efectivo a ventas de Vertex Pharmaceuticals?
El ratio de efectivo a ventas de Vertex Pharmaceuticals es 10.57
¿Cuál es la moneda de reporte de Vertex Pharmaceuticals?
Vertex Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Vertex Pharmaceuticals?
El último ingresos anual de Vertex Pharmaceuticals es USD 9.92B
¿Cuál es el último beneficio anual de Vertex Pharmaceuticals?
El último beneficio anual de Vertex Pharmaceuticals es USD 3.57B
¿Cuál es la dirección registrada de Vertex Pharmaceuticals?
La dirección registrada de Vertex Pharmaceuticals es 50 NORTHERN AVENUE, BOSTON, MASSACHUSETTS, 02210
¿Cuál es la dirección del sitio web de Vertex Pharmaceuticals?
La dirección del sitio web de Vertex Pharmaceuticals es www.vrtx.com
¿En qué sector industrial opera Vertex Pharmaceuticals?
Vertex Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
benz280c benz280c 4 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 11 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 12 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 15 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 20 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 21 minutos hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 26 minutos hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 28 minutos hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 29 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 31 minutos hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 34 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 37 minutos hace
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 37 minutos hace
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 38 minutos hace
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 39 minutos hace
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 41 minutos hace
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 55 minutos hace
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 57 minutos hace
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII
Jane1999 Jane1999 57 minutos hace
Here the CEO : https://www.wsj.com/market-data/quotes/CA/XCNQ/TWOH/company-people/executive-profile/149699
TWOH
Curious Bystander Curious Bystander 59 minutos hace
The Expert Market was set up by the SEC for several very specific reasons. But you could generally say that a security lands in that market when a company is either UNABLE or UNWILLING to file certain SEC-required forms.

UNABLE or UNWILLING. Hmmmm…..I wonder which category Quantum
FLCX
CometNebula81 CometNebula81 1 hora hace
What is everyone's opinion on if or when dividends may be restored and if so what much would we be looking at in dividends? Let's you have 100,000 shares what would you be getting every year?
FNMA
Steady_T Steady_T 1 hora hace
Wouldn't the MABS have to be better than donepezil and memantine to get approved making them the new SOC?

That doesn't mean the MABS are selling well.
AVXL
mrwhippy458 mrwhippy458 1 hora hace
Somewhat true. Once it's at 250m OS, they need to bring that market cap up so we can start seeing dollars
ABQQ
CrossFireTrader CrossFireTrader 1 hora hace
Actually Alocations are given to Dealerships based on how many Vettes they have sold in prior years 25 years ago I lived in Los Angeles and there was a small city Montclair about 10 15 south of Pasadena there was a Dealership there Richard Hibbard Chevrolet and he got more Vettes than anyone in the
GDVM

Su Consulta Reciente

LSE
0QZU
Vertex Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados